A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years. “This is ...

Like other CAR-Ts, Calibr's therapy is manufactured from a patient's own T-cells, which are harvested and genetically modified to fight cancer before being reintroduced into the body.

Rogers Communications Inc. Cl A-1.67% $21.72B Rogers Communications Inc. Cl B 1.11% $21.72B ...

After hours: February 19 at 6:00:00 PM EST Loading Chart for MTB ...

Huber won't hold a large position in a stock simply because of its yield, though. In times of heightened uncertainty, Huber emphasizes nonyield characteristics, including valuation, balance-sheet ...